Ali Haghighi-Mood, PhD
Co-Founder, CEO & Board Member
Ali Haghighi-Mood is the co-founder and CEO of Sirona Medical. He has more than 20 years hands-on experience in various capacities in the biomedical device industry including research and development, operations and regulatory/clinical affairs. His experience includes more than 17 years in executive positions and 13 years as CEO in both public and private companies in the cardiac electrophysiology space. Prior to Sirona, Ali Served as the President and CEO of Cambridge Heart, acquired by Spacelabs Healthcare in 2015. In his various executive positions he managed the development of several electrophysiology products, from concept to commercialization including obtaining regulatory approval and reimbursement coverage. He has invented multiple patent protected innovations in the electrophysiology space. He holds BS and MS degrees in Electrical Engineering from the University of Tehran and a PhD degree in Biomedical Engineering from the University of Sussex, UK
Richard J. Cohen, MD, PhD
Co-Founder & Chief Scientist
Richard J. Cohen is the Whitaker Professor in Biomedical Engineering at the Massachusetts Institute of Technology (MIT) and in the Harvard-MIT Health Sciences and Technology (HST) program. He received an MD degree from Harvard Medical School and a PhD degree in Physics from MIT. He has authored over 270 journal articles and is an inventor on more than 35 US patents. He directed HST’s Center for Biomedical Engineering and the NASA Center for Quantitative Cardiovascular Physiology, Modeling and Data Analysis at MIT. Dr. Cohen has consulted for many biomedical companies and served on boards of directors and scientific advisory boards. He co-founded two biomedical companies. For nine years he co-directed the Biomedical Enterprise Program - a combined MS/MBA program run jointly by HST and the MIT Sloan School of Management. He currently helps direct the Sloan Healthcare Certificate program.
Chief Technology Officer
Jeff Kraus is the Vice President of Engineering at Cathx Medical, leading the design and manufacturing of Sirona's products. He is an experienced mechanical engineer with more than 25 years experience in building teams and managing the design, development and manufacturing of innovative advanced catheter products. He has been a founder and co-founder of three catheter design and manufacturing companies with successful M&A exits, including AdvancedCath Medical Act Medical and Cathx Medical. Jeff is the primary author of more than 15 US and international patents in the medical device field. Jeff holds a mechanical engineering degree from San Jose State University.
Board of Directors
Burt Adelman, MD
Co-founder and Chairman at Verve Therapeutics. Formerly Executive Vice President and Chief Medical Officer at Dyax Corporation, acquired by Shire pharmaceuticals in January 2016. More than 30 years executive experience in the life sciences space including the development of Angiomax, Avonex, Amevive and Tysabri. Dr. Adelman recieved an MD degree from Cornell University Medical College.
David Cohen, MBA
Executive Vice President at Standard Oil of Connecticut, Inc., Founder and co-founder of a number of highly successful ventures, including: Standard Security Systems, ResCom Energy, Moneo Technology Solutions, My Gene Counsel, Standard Oil Ventures. David holds a BA degree from Harvard College, and an MBA degree from Harvard Business School.
Roderick deGreef, MBA
President and COO at BioLife Solutions (NASDAQ:BLFS) after serving as CFO since March 2016. Experienced executive with a demonstrated track record of building teams and managing financial operations, raising debt and equity capital, negotiating and structuring strategic M&A and commercial transactions, and implementing investor relations programs. Roderick holds a BA degree in Economics and International Relations from San Francisco State University and an MBA degree from University of Oregon.
David Wurzer, BBA
Executive Vice President and Chief Investment Officer at Connecticut Innovations, also responsible for oversight of the Connecticut Bioscience Innovation Fund (CBIF) and the Regenerative Medicine Research Fund (RMRF). Extensive senior-level experience in operations, finance, and forming strategic partnerships and business development alliances, including more than 10 years as executive vice president, treasurer, and CFO of CuraGen, where he guided the company through its IPO, and helped to grow the company into an operation with more than 500 employees and a market capitalization of $5.3 billion.
David holds a BBA degree in accountancy form the University of Notre Dame.